Heart Attack News and Research

RSS

Study suggests new treatment strategy for heart attacks and strokes

A heart attack doesn't just damage heart muscle tissue by cutting off its blood supply, it also sets off an inflammatory cascade that worsens underlying atherosclerosis, actively increasing the risk for a future heart attack. These findings from a study receiving advance online publication in Nature suggest an important new therapeutic strategy for preventing heart attacks and strokes, both of which are caused when atherosclerotic plaques rupture and block important blood vessels.

28 Jun 2012

Arena receives FDA approval for Belviq to treat obesity

The U.S. Food and Drug Administration today approved Belviq (lorcaserin hydrochloride), as an addition to a reduced-calorie diet and exercise, for chronic weight management.

28 Jun 2012

Scientists reverse diabetes in mice using stem cells

University of British Columbia scientists, in collaboration with an industry partner, have successfully reversed diabetes in mice using stem cells, paving the way for a breakthrough treatment for a disease that affects nearly one in four Canadians.

28 Jun 2012

Broken heart syndrome may protect the heart from adrenaline overload

A condition that temporarily causes heart failure in people who experience severe stress might actually protect the heart from very high levels of adrenaline, according to a new study published in the journal Circulation. The research provides the first physiological explanation for Takotsubo cardiomyopathy, also called "broken heart syndrome" because it affects people who suffer severe emotional stress after bereavement, and suggests guidance for treatment.

27 Jun 2012

Study finds increase in incidence of gout and hyperuricemia in the U.S.

Researchers from Boston University School of Medicine (BUSM) have found that the incidence of gout and hyperuricemia (high uric acid levels) in the U.S. has risen significantly over the last 20 years and is associated with major medical disorders like hypertension and chronic kidney disease.

27 Jun 2012

First clinical trial to test cardiac drug regimen for DMD

The first landmark randomized clinical trial for a cardiac drug regimen in Duchenne muscular dystrophy (DMD) is testing whether earlier treatment can stop or slow down heart damage that usually kills people with the disease.

27 Jun 2012

International observers hopeful about Malawian President Banda's agenda for maternal health

"Any new president has a vast array of items on his or her agenda, but newly inaugurated Malawian President Joyce Hilda Banda has elevated a praise-worthy agenda for maternal health at the very outset of her time in office," Alisha Kramer, a research assistant at the Center For Strategic & International Studies' (CSIS) Global Health Policy Center, writes in this post in the center's "Smart Global Health" blog.

26 Jun 2012

Researchers develop inexpensive system that offers benefits of cardiac rehabilitation programmes

Researchers at the Universidad Poltécnica de Madrid (UPM) have developed an inexpensive system that offers the benefits of cardiac rehabilitation programmes for patients who currently cannot access them.

26 Jun 2012

Enrollment commences in Stealth Peptides' Bendavia Phase II clinical study for acute STEMI

Stealth Peptides Incorporated, a privately held biopharmaceutical company developing innovative therapies for cardiovascular disease and its complications, announced today that the first patient was enrolled in its multinational Phase II clinical study with Bendavia focused on ischemia reperfusion and microvascular injuries for patients experiencing acute ST-segment elevation myocardial infarction.

25 Jun 2012

Common experience of menopausal symptoms not associated with heart disease risk

The hot flashes and night sweats that most women experience early in menopause are not linked to increased levels of cardiovascular disease risk markers unless the symptoms persist or start many years after menopause begins. These new study results will be presented Saturday at The Endocrine Society's 94th Annual Meeting in Houston.

25 Jun 2012

Researchers uncover why ointment and photodynamic therapy cause pain in skin cancer patients

Apply the ointment, light on, light off - that's how easy it is to cure various forms of non-melanoma skin cancer. However, the majority of patients suffer severe pain during the so-termed photodynamic therapy.

23 Jun 2012

Janssen receives FDA complete response letter for XARELTO sNDA

Janssen Research & Development, LLC (Janssen R&D) announced today the U.S. Food and Drug Administration (FDA) issued a complete response letter regarding a supplemental New Drug Application (sNDA) for XARELTO (rivaroxaban) for the reduction of the risk of secondary cardiovascular events in patients with acute coronary syndrome (ACS).

22 Jun 2012

First study to demonstrate long-term and sustained cardiac benefit for patients after gastric bypass

Total cholesterol, triglycerides and C-reactive protein levels are among 11 risk factors for heart attack that remained greatly reduced up to seven years after gastric bypass surgery, according to a new Stanford University study presented here at the 29th Annual Meeting of the American Society for Metabolic & Bariatric Surgery.

21 Jun 2012

Tinkering with p190RhoGAP molecule shapes development of cardiac stem cells

Johns Hopkins researchers have discovered that a single protein molecule may hold the key to turning cardiac stem cells into blood vessels or muscle tissue, a finding that may lead to better ways to treat heart attack patients.

21 Jun 2012

One in eight people with heart attack experience significant symptoms of PTSD

One in eight people who suffer a heart attack or other acute coronary event experience clinically significant symptoms of post-traumatic stress disorder (PTSD), according to a meta-analysis of 24 studies led by Columbia University Medical Center researchers.

21 Jun 2012

Large proportions of European coronary patients do not benefit from cardiac rehabilitation services

Large proportions of European coronary patients are not benefitting from cardiac rehabilitation services, according to results of the third EUROASPIRE survey published today in the European Journal of Preventive Cardiology.

20 Jun 2012

C-section rates in US stabilize after eight years of steady increase

A new report on trends in women's health in the United States reveals the national C-section rate has held steady at 33 percent since 2009, leveling off after eight years of steady increase that was in part driven by scheduled, elective surgeries and a trend for increasing the repeat C-section.

19 Jun 2012

Heart transplant patients who develop restenosis after receiving a stent have poor long-term survival

Heart transplant patients are notorious for developing an aggressive form of coronary artery disease that can often result in heart failure, death or the need for repeat transplantation. The condition can also have a negative impact on future cardiac procedures, such as stenting.

19 Jun 2012

Coronary risk for chronic kidney disease patients could be as high as for those who have had a heart attack

Patients suffering from chronic kidney disease could be at as high a risk of coronary heart disease as patients who have previously had a heart attack, according to an Article published Online First in the Lancet.

19 Jun 2012

Glutathione peroxidase can dramatically reduce risk of cardiovascular disease

University of Minnesota Medical School researchers have collaborated with the School of Public Health and discovered an enzyme that, when found at high levels and alongside low levels of HDL (good cholesterol), can dramatically reduce the risk of cardiovascular disease.

16 Jun 2012

Heart Attack News and Research

Study suggests new treatment strategy for heart attacks and strokes

Arena receives FDA approval for Belviq to treat obesity

Scientists reverse diabetes in mice using stem cells

Broken heart syndrome may protect the heart from adrenaline overload

Study finds increase in incidence of gout and hyperuricemia in the U.S.

First clinical trial to test cardiac drug regimen for DMD

International observers hopeful about Malawian President Banda's agenda for maternal health

Researchers develop inexpensive system that offers benefits of cardiac rehabilitation programmes

Enrollment commences in Stealth Peptides' Bendavia Phase II clinical study for acute STEMI

Common experience of menopausal symptoms not associated with heart disease risk

Researchers uncover why ointment and photodynamic therapy cause pain in skin cancer patients

Janssen receives FDA complete response letter for XARELTO sNDA

First study to demonstrate long-term and sustained cardiac benefit for patients after gastric bypass

Tinkering with p190RhoGAP molecule shapes development of cardiac stem cells

One in eight people with heart attack experience significant symptoms of PTSD

Large proportions of European coronary patients do not benefit from cardiac rehabilitation services

C-section rates in US stabilize after eight years of steady increase

Heart transplant patients who develop restenosis after receiving a stent have poor long-term survival

Coronary risk for chronic kidney disease patients could be as high as for those who have had a heart attack

Glutathione peroxidase can dramatically reduce risk of cardiovascular disease

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News